GAMMA Investing
CLPT icon

GAMMA Investing’s ClearPoint Neuro CLPT Stock Holding History

GAMMA Investing’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.75K Buy
553
+121
+28% +$1.82K ﹤0.01% 3533
2026
Q2 		$7.71K Buy
432
+161
+59% +$2.01K ﹤0.01% 3311
2026
Q1 		$2.47K Buy
271
+38
+16% +$480 ﹤0.01% 3596
2025
Q4 		$3.19K Buy
233
+162
+228% +$3K ﹤0.01% 3455
2025
Q3 		$1.55K Buy
+71
New +$836 ﹤0.01% 3516
2024
Q3 		– Sell
-42
Closed -$226 – 3602
2024
Q2 		$226 Hold
42
– – ﹤0.01% 3307
2024
Q1 		$286 Hold
42
– – ﹤0.01% 3189
2023
Q4 		$292 Buy
+42
New +$238 ﹤0.01% 3063

Other funds holding CLPT

Lodestone Wealth Management
Lodestone Wealth Management Spokane, Washington $297M AUM 25.27% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
City State Bank
City State Bank Norwalk, Iowa $441M AUM 23.97% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

GAMMA Investing's CLPT Position: Q3 2026 in Review

GAMMA Investing increased its ClearPoint Neuro (CLPT) stake by 28% in Q3 2026, buying an estimated $1.82K and bringing the position to 553 shares worth $6.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3533.

GAMMA Investing first reported a position in CLPT in Q4 2023 and has held it in 8 quarters since. The position peaked at $7.71K in Q2 2026. 9 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • GAMMA Investing held 553 shares of ClearPoint Neuro worth $6.75K as of Q3 2026.
  • GAMMA Investing bought 121 ClearPoint Neuro shares in Q3 2026, an estimated $1.82K.
  • ClearPoint Neuro made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3533 holding.
  • GAMMA Investing first reported a position in ClearPoint Neuro in Q4 2023 and has held it in 8 quarters since.
  • GAMMA Investing's ClearPoint Neuro position peaked at $7.71K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.